Clinical Trial Update: A Study of ONO-7018 in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial update for ONO-7018 in relapsed or refractory Non-Hodgkin lymphoma; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• ONO-7018

Snippet

Sponsor: Ono Pharmaceutical Co., Ltd. | Conditions: Non Hodgkin Lymphoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING